1. Protective effects of Qing-Re-Huo-Xue formula on bleomycin-induced pulmonary fibrosis through the p53/IGFBP3 pathway.
- Author
-
Yang, Fangyong, Du, Wenjing, Tang, Zhao, Wei, Ying, and Dong, Jingcheng
- Subjects
BIOLOGICAL models ,BIOCHEMISTRY ,IDIOPATHIC pulmonary fibrosis ,HERBAL medicine ,PULMONARY surfactant ,IN vivo studies ,ANIMAL experimentation ,IMMUNOHISTOCHEMISTRY ,PHENOMENOLOGICAL biology ,ONCOGENES ,CELL physiology ,CELLULAR signal transduction ,DIAGNOSTIC imaging ,ELECTRON microscopy ,GENE expression ,PROTEOMICS ,TREATMENT effectiveness ,PULMONARY function tests ,RESEARCH funding ,MESSENGER RNA ,BLEOMYCIN ,POLYMERASE chain reaction ,CHINESE medicine ,MICE ,CARRIER proteins ,DRUG administration ,DRUG dosage ,THERAPEUTICS - Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing lung disease with high mortality. Inflammation and epithelial mesenchymal transformation (EMT) may play an important role in the occurrence and development of IPF. Qing-Re-Huo-Xue formula (QRHXF) has been used clinically by our team for half a century and has obvious therapeutic effects on lung disease. Nevertheless, the role and mechanism of QRHXF in the treatment of IPF have never been studied. Methods: A mouse pulmonary fibrosis model was established by intratracheal injection of BLM. The effects of QRHXF on the treatment of pulmonary fibrosis were studied by pulmonary function testing, imaging examination, pathological staining, transmission electron microscopy (TEM) observation and mRNA expression. Tandem mass tag (TMT)-based quantitative proteomics was carried out to analyse the lung protein expression profiles between the control (CTL), bleomycin (BLM) and QRHXF (BLM + QRHXF) groups. Immunohistochemistry and qRT-PCR were used to verify the possible existence of drug target proteins and signalling pathways. Results: The results of pulmonary function, lung pathology and imaging examinations showed that QRHXF could significantly alleviate BLM-induced pulmonary fibrosis in vivo. Additionally, inflammatory cell infiltration and EMT were markedly reduced in BLM-induced PF mice administered QRHXF. Proteomics detected a total of 35 proteins, of which 17 were upregulated and 18 were downregulated. A total of 19 differentially expressed proteins (DEPs) overlapped between the BLM versus CTL groups and the BLM + QRHXF versus BLM groups. The expression of p53 and IGFBP3 was reversed in the QRHXF intervention group, which was verified by immunohistochemistry and qRT-PCR. Conclusions: QRHXF attenuated BLM-induced pulmonary fibrosis, and regulation of the p53/IGFBP3 pathway might be associated with its efficacy, which holds promise as a novel treatment strategy for pulmonary fibrosis patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF